Navigation Links
Physicians' Cancer Chemotherapy Drug Manual 2005

ProductsPhysicians' Cancer Chemotherapy Drug Manual 2005
Company Skyscape, Inc.
Item Physicians' Cancer Chemotherapy Drug Manual 2005
Features 
  • Special information profiling anti-emetic drugs
  • Complete discussion of clinical pharmacology, indications, and dosages
  • Coverage of toxicity and interactions
  • Section on chemotherapy regimens for specific cancers
  • Overview of basic principals of cancer drug therapy
Description Completely revised and updated for 2005, this practical handbook is an up-to-date guide to all aspects of cancer chemotherapy. The book provides a comprehensive, easy to use catalog of over 100 drugs both on and off label commonly used in cancer treatment. This new edition includes new agents (recently or about to be FDA approved).
Info Skyscape, Inc.
Customer Service: 508-460-6500
Web site: http://www.skyscape.com/index/home.aspx

Related medicine products :

1. Breast Cancer Camera
2. Cancer Antigen 125 (Trademark of Fujirebio Diagnostic Inc.)
3. Vysis UroVysion Bladder Cancer Kit
4. Pocket Guide to Colorectal Cancer Drugs and Treatment
5. Cochrane Reviews in Prostatic Diseases and Urologic Cancers
6. AFP (Liver Cancer)
7. Alpha Fetoprotein (Liver Cancer)
8. NMP22 Bladder Cancer ELISA Test Kit
9. BRAF V600E Detection of Colon Cancer (Unstable Tumors) by PCR
10. Cancer Antigen 27.29
11. Cancer Antigen 125
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products:
(Date:5/16/2008)...rstCall/ -- Tempo Participacoes,S.A. (Bovespa: TEM...ding,provider of healthcare administration service... services, announces today its results for the fir...formation contained herein,except where otherwise...,accordance with Brazilian Stock Exchange Commissi...
(Date:5/15/2008)...sing in Targeting Cancer Cells, ...ay 15 /PRNewswire-FirstCall/ -- Abbott scientists,...everal investigative,compounds in the company,s on... Clinical Oncology (ASCO) Annual Meeting, schedule... ABT-263, a Bcl-2 family protein,antagonist, and A...
(Date:5/15/2008)...ng cancer treatment for each individual, researche...resented a study suggesting a simple blood test ca...cacy for patients with metastatic breast cancer. ,...to determine if a particular cancer treatment is w...y significant radiographic changes in tumor size o...
(Date:5/15/2008)...tCall/ -- Digital Power,Corporation (Amex: DPW ) ...cial results for the first quarter ended March 31,...000 for the quarter ended,March 31, 2008, an incre...last year. An operating loss of $165,000 for the f...operating profit of $25,000 for the same quarter,l...
Breaking Medicine News(10 mins):Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 2Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 3Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 4Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 5Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 6Health News:Study suggests blood test can help improve treatment outcomes for breast cancer patients 2Health News:Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008 2Health News:Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008 3
... North America with an estimated 400,000 people fa...of these //people have their hearts pumping again ...of the main causes of death after the heart is res...esented at the 2006 Society for Academic Emergency...
...cos here have collapsed due to fasting in the past...fight against// reservation for backward classes w...ecision. "Ninety-four doctors have so far collapse...e hunger strike. Currently 35 of them are still si...
...people to get themselves screened for HIV, city-ru...criteria// for HIV testing. According to the new r...ent is not neccessary for voluntary HIV/AIDS testi...consent from the patient. This rule makes it the ...
...e discovered the cause for people to overeat. Scie...it's in the brain//. Researchers at the council's... the first neurobiological proof as to why some pe...research, published today in the Journal of Neuros...
Other Medicine News:Health News:Survival After Cardiac Arrest Is Aided By Cooling 2Health News:Despite Collapse Of The Medicos Strike To Continue Unabated 2Health News:Research Scans Explain Why People Crave For Food 2
(Date:5/15/2008)...Antiplatelet Therapy that, Combined, with Aspirin,...ix/Iscover and Aspirin, According to a New Rep...15 /- Decision Resources, one of the,...armaceutical and,healthcare issues, finds that Dai... in patient compared to Sanofi-Aventis/Bristol Mye...
(Date:5/15/2008)...ares Genous, Boston Scientific,s ...on Real-World Use of Genous, Stent,s Performance ... Dual-Antiplatelet ... OrbusNeich today announced,that multiple clinical...,support the use of the company,s Genous Bio-engin...
(Date:5/14/2008)...ire-FirstCall/ -- Progen,Pharmaceuticals Limited (...mpany has resumed patient enrolment in the phase 1...lyamine analogue, PG-11047 (formerly CGC-11047),fo...enced development of PG-11047 - the lead clinical,...owing its acquisition of,Cellgate, Inc earlier thi...
(Date:5/14/2008)... for cervical cancer prevention, GRAZ, Austria, M...xtended follow-up study show that GlaxoSmithKline ...ERVARIX(R) generates sustained high levels of,neut...rvical cancer-causing,human papillomavirus types f...f sustained neutralizing antibody levels observed ...
Breaking Medicine Technology:Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 4Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 2CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 3CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 4CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 5CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 6EaglePicher Medical Power Names Joseph Marotta Vice President of Sales and Marketing 14008 1EaglePicher Medical Power Names Joseph Marotta Vice President of Sales and Marketing 14008 2Colon Cancer Screening Laws Now Cover Half of U S Population 3861 1Colon Cancer Screening Laws Now Cover Half of U S Population 3861 2Colon Cancer Screening Laws Now Cover Half of U S Population 3861 3Colon Cancer Screening Laws Now Cover Half of U S Population 3861 4Colon Cancer Screening Laws Now Cover Half of U S Population 3861 5DURECT to Participate in Cowen Annual Healthcare Conference 14005 1Outcomes Improve for Non Hodgkin Lymphoma Patients 14002 1Outcomes Improve for Non Hodgkin Lymphoma Patients 14002 2
...-(BUSINESS WIRE)--May 10, 2007 - According to,The ...ercent of,female respondents seeking treatment for...killers such as Vicodin, OxyContin, Percocet,and F...5 percent of,the mothers who reported a dependency...Clare Waismann, registered addiction,specialist fo...
...May 10th, 2007 - Antisense,Pharma today announced,...ults of a Phase I/II-Study in Pancreatic,Carcinoma...h the,TGF-beta2 Inhibitor AP 12009” has been...al Meeting of the American Society of,Clinical Onc...ois,U.S.A, from June 1st - 5th. , In the Phase I/...
Other Medicine Technology:Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 2Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor,AP 12009 to be Presented 2